In clinical studies the numbers are unusual for a sleep aid: DSIP increased total sleep time by about 59% in one trial, normalized sleep in people with chronic insomnia in another, and, most strikingly, several of those patients kept normal sleep for 3 to 7 months after their last injection
LiaY: Formal analysis, Resources, Visualization, Writing review & editing
Free Radic Biol Med 93, 110117.CrossRefGoogle ScholarPubMed Sonthalia, S, Jha, AK, Lallas, A, et al
found that GLP-1RAs did not significantly reduce asthma exacerbations, whereas, SGLT-2 inhibitors (SGLT-2i) were associated with a reduced risk of asthma compared to both GLP-1RAs and DPP-4 inhibitors (DPP-4i) [101]
(11) Zh Sh Zhumadilov, and R P Terekhova (1985) [Use of thymalin for preventing postoperative suppurative and inflammatory complications] Klin Khir (1962), 1985 Jan:(1), Pages 36-8